Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 2:25 PM
Ignite Modification Date:
2025-12-25 @ 1:00 PM
NCT ID:
NCT00911859
Group ID:
EG000
Title:
Part 1: VMP (Velcade+Melphalan+Prednisone) + Siltuximab
Description:
Siltuximab 11 mg/kg as a 1-hour intravenous infusion every 3 weeks along with VMP. VMP: Velcade 1.3 mg/m2 was administered as an intravenous bolus injection according to the current approved package inserts. Melphalan 9 mg/m2 and prednisone 60 mg/m2 were taken orally.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
8
Serious Number At Risk:
12
Other Number Affected:
12
Other Number At Risk:
12
Study:
NCT00911859
Results Section:
NCT00911859
Adverse Events Module:
NCT00911859